🧠 Healthy Brain, Healthy Gains

Plus, the hidden cost of US trade policies? (Hint: Not tariffs.)

HAPPY WEDNESDAY TO THE STREET.

Nvidia $NVDA ( ā–¼ 1.36% ) earnings are in. The results? A top- and bottom-line beat, naturally! The chip giant posted annual revenue growth of 69% and shattered the previous quarter’s sales record.

The stock rose in aftermarket trading. But don’t get your hopes too high for a sharp gain tomorrow. High hopes, after all, are exactly Nvidia’s problem right now.

For example, revenue in its key data center segment rose 73% year-over-year. It still fell short of analyst expectations.

Its earnings per share also rose 33% annually. But that’s far less than the >70% gains it posted for the past seven quarters straight.

Shakespeare once wrote, ā€œExpectation is the root of all heartache.ā€ His classic wisdom may continue to ring true today. Then again, he also wrote, ā€œI am pigeon-liver’d and lack gall.ā€ So who are we to say?

  • 🟄 | US stocks ticked down ahead of the aforementioned report from the world’s second most valuable company by market cap.

  • šŸ“ˆ | One Notable Gainer: Air taxi maker Joby Aviation $JOBY ( ā–¼ 3.94% ) lifted off after securing a $250M investment from Toyota $TM ( ā–¼ 1.89% ).

  • šŸ“‰ | One Notable Decliner: Identity management firm Okta $OKTA ( ā–¼ 1.35% ) is having an identity crisis, warning that customers have become ā€œmore cautiousā€ amid economic uncertainty.

— Brooks & Cas

Sponsored by RYSE

Consumer electronics may have dodged the tariff bullet, but one smart home disruptor isn’t waiting for luck. 

They’ve strategically secured production outside China, staying ahead of the global manufacturing shift.

That’s exactly how this company has hit 200% year-over-year growth while expanding into over 120 major retail locations.

Their smart shade technology is reshaping home automation, protected by patents and backed by powerful retail partnerships.

Smart investors spot the pattern: companies that turn global challenges into strategic wins often deliver the biggest returns.

At just $1.90 per share, you’re looking at a company that’s not just prepared for supply chain shifts — it’s already capitalizing on them.

STOCK HEATMAPS

S&P 500 Heatmap. Credit: Finviz

All Stock Heatmap. Credit: Finviz

Global ADR snapshot. Credit: Finviz

Market Movers

ABERCROMBIE & FITCH, GAMESTOP, VAIL RESORTS

$ANF ( ā–² 4.59% ) Abercrombie Surges on Raised Outlook After Tallying Tariff Cost (Bloomberg)

$GME ( ā–¼ 1.67% ) Investors flee GameStop following $500 million Bitcoin splurge (Fortune)

$MTN ( ā–² 0.44% ) Vail Resorts Stock Soars as Company Brings Back Former CEO (Investopedia)

$CDNS ( ā–² 0.64% ) / $SNPS ( ā–² 1.9% ) Chip software stocks sink on report Trump ordered halt to China sales (CNBC)

$BOX ( ā–¼ 1.61% ) Box Stock Surges After Strong First-Quarter Earnings Report (Barron’s)

OVERHEARD ON THE STREET

CNBC: Mortgage rates reached their highest level since January last week, but purchase applications climbed as well.

Reuters: The Federal Reserve’s May minutes showed rising recessionary risks, although the meeting was held before the US-China tariff pause.

CBS: Elon Musk criticized President Trump’s ā€œbig, beautifulā€ budget bill, arguing it will undermine DOGE spending cuts.

TheStreet: At a Bitcoin conference, Vice President Vance decried crypto regulation and said the White House will ā€œchampionā€ the technology.

WSJ: e.l.f. Beauty $ELF ( ā–¼ 1.23% ) will acquire Hailey Bieber’s beauty brand Rhode in a $1B deal.

Tomorrow's Trade Idea, Today

HIDDEN HEALTH GEM

UBS Sees Upside

UBS $UBS ( ā–² 0.03% ) took a strong stance on LifeStance Health $LFST ( ā–¼ 0.34% ).

The bank upgraded the online therapy stock to a Buy, arguing that it's undervalued relative to its performance. Its $8.50 price target represents a more than 40% upside from current prices.

UBS believes recent market pessimism surrounding the stock, rooted in conservative earnings guidance and incentive changes, is overshadowing the company’s fundamental strength and long-term growth potential.

Overblown Concerns

Analyst Kevin Caliendo argues that investor fears are overstated, particularly regarding policy shifts and internal compensation changes.

He emphasized confidence in LifeStance’s business model ā€” citing consistent clinician growth above 10% annually ā€” as well as its refreshed leadership. The firm named a new CEO in February and a new CTO earlier this week.

The company also has a solid cash position and manageable debt, and Caliendo believes it is well-equipped to fund future growth initiatives, including those not seen in its 2025 forecast.

Time to Buy

Despite an 18% drop in its share price YTD, Caliendo thinks buying the dip is the right move. He is confident that its long-term growth potential remains intact, fueled by strong demand in a large and underserved market.

Finally, UBS highlighted its favorable risk/reward ratio and positive secular trends. That, combined with its strong fundamentals, business, and management, could potentially provide a great buying opportunity.

The prognosis may remain guarded. But UBS believes LifeStance has the right treatment plan to make a healthy recovery.

Are you bullish or bearish on LifeStance Health (LFST) over the next 12 months?

Login or Subscribe to participate in polls.

Sponsored by Survey Junkie

Surveys can be an afterthought — whether it’s the questionnaire after a plane ride or the nudge to provide feedback when a meal at a restaurant is over. 

But that was before Survey Junkie came along with a model that boosts both brands and personal incomes. 

Owned by consumer insights platform DISQO — which delivers data and analytics to the market research industry — Survey Junkie has welcomed more than 20 million lifetime members. 

Each one has gotten paid to complete surveys or participate in a focus group. 

Every day, hundreds of brands you know and love turn to DISQO for consumer insights. The information shared by the Survey Junkie community powers that research, bettering products — and making you money in the process

ON OUR RADAR

AP: ā€œWrench attacksā€ on crypto whales are rising. Here’s what that means.

Observer: In its latest test flight, SpaceX’s Mars-colonizing Starship lost control on re-entry, but still showed signs of progress.

WSJ: Thousands of North Koreans are secretly working remotely in the US through an intricate ā€œlaptop farm" scheme.

Fortune: UnitedHealth $UNH ( ā–¼ 1.51% ) is facing a new lawsuit, which alleges it illegally used ex-workers’ funds to reduce its own 401(k) contributions.

CNBC: The hidden cost of the US’s controversial trade policies may be a decline in tourism — which could cost the nation more than $8B.

TUESDAY’S POLL RESULTS

Are you bullish or bearish on Tesla $TSLA ( ā–¼ 14.26% ) over the next 12 months?

▇▇▇▇▇▇ šŸ‚ Bullish

▇▇▇▇▇▇ šŸ» Bearish

And, in response, you said:

  • šŸ‚ Bullish — ā€œI still believe this and all of Elon’s companies are the tech of the future. Electric cars, xAI, robots, self-driving cars/taxis, rockets, and Starlink. Who's not watching???ā€

  • 🐻 Bearish — ā€œMusk will never recapture his ā€˜fan boys’ again... and as for his robo-taxis and trucks... I'll believe it when I see it!ā€

This message includes a paid advertisement for RYSE Inc. The Street Sheet (SS) receives a flat fee from RYSE Inc totaling up to $7,500. Other than the compensation received for this advertisement sent to subscribers, The Street Sheet and its principals are not affiliated with RYSE Inc. This advertisement is sponsored by a third-party Reg A crowdfunding issuer and is for informational purposes only. The Street Sheet does not endorse or recommend any specific offering, and this advertisement should not be construed as a recommendation to invest. Investing in securities, including those offered through Reg A crowdfunding, involves risk, including the potential loss of principal. These investments are speculative, illiquid, and may involve a higher degree of risk compared to more traditional investments. The Street Sheet has not verified the information provided by the advertiser, and we encourage readers to conduct their own due diligence and consult with a licensed financial advisor or other qualified professional before making any investment decision. By engaging with this advertisement, you acknowledge that The Street Sheet and its affiliates are not responsible for any decisions or actions taken based on the information provided in this advertisement. All investments carry risks, and past performance is not indicative of future results. Readers should carefully review all information provided by the issuer, including the offering circular and any other available materials, prior to investing. The Street Sheet may receive compensation from the advertiser for promoting this offering. The Street Sheet and its principals do not own any of the stocks or shares mentioned in this email or in the article that this email links to. The Street Sheet is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to accuracy or completeness. Each user of SS chooses to do trades at their sole discretion and risk. SS is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SS receives some sort of compensation is clearly and prominently identified herein as "ad", "Sponsored", or ā€œTogether Withā€. Although we have sent you these advertisements, SS does not specifically endorse any third-party product nor is it responsible for the content, the accuracy, or the completeness of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is in the advertisement. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. This communication from The Street Sheet is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of The Street Sheet. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. The information contained in this newsletter is subject to change without notice, and we do not undertake any obligation to update it. Readers are encouraged to conduct their own research and due diligence and seek advice from licensed professionals regarding their specific financial needs and circumstances. By reading this newsletter, you agree to hold us harmless from any and all losses, liabilities, costs, or expenses arising from your use or reliance on the information provided. There is no warranty as to the accuracy or completeness of the factual matters included in any advertisement or sponsored content in the newsletter. You have not performed any research on any entity, or its business, that advertises or submits any sponsored content. The Street Sheet is reader-supported. When you buy through links on our site, we may earn a commission.

Reply

or to participate.